68 jobs for “Biotech Research Scientist”
GSK London £123,000 – £205,000 pa
Leads respiratory epidemiology and real-world evidence programmes that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners with clinical development, safety, regulatory and external collaborators, and mentors junior staff. Requires deep RWE and pharmaco-epidemiology expertise in a global, matrixed environment.
GSK Wavre, Belgium €123,000 – €205,000 pa
Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, owning the epidemiology plan for at least one asset or disease area. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory teams, and manages external partnerships while mentoring junior scientists.
Isomorphic Labs Cambridge, United States
Lead the safety assessment strategy for small molecule and biologic drug discovery projects from inception to regulatory submission, designing screening cascades and mechanistic experiments. Partner with machine learning researchers to build predictive toxicology models and manage CRO relationships for outsourced wet-lab data generation, while mentoring junior team members.
Mytos London
Open general application for a London-based biotech automation company building machines that fully automate human cell production. The team, drawn from ex-Dyson engineers and Nature-published scientists, seeks people with a track record of solving hard technical or non-technical challenges, low ego and high curiosity, including those starting their first job.
Isomorphic Labs London
Owns safety assessment strategy for drug discovery projects from inception to regulatory submission, working with small molecule and biologics platforms. Designs screening cascades, authors IND packages, and manages CRO relationships for outsourced wet-lab work. Also guides development of an AI predictive toxicology platform with ML researchers.
Vertex Pharmaceuticals London
A 12-month industrial placement within an international Medical Affairs team, supporting the planning and execution of medical projects in assigned therapeutic areas. The role involves project management, monthly dashboard reporting, managing external agencies, monitoring budgets for medical education events and advisory boards, and liaising with cross-functional and external stakeholders.
Vertex Pharmaceuticals London
Leads the development and execution of international regulatory strategy across European and Rest of World markets, from first-in-human through post-marketing. Represents Global Regulatory Affairs on core development teams, manages project plans and resources, and advises senior management. Also a people manager within the International GRA leadership team, driving process improvement and regulatory policy engagement.
Relation Therapeutics London
Senior project manager role coordinating a multi-year osteoporosis drug discovery programme across target ID, hit-to-lead, lead optimisation and candidate selection. Involves orchestrating matrixed wet lab, ML, data science and engineering teams plus CROs, managing plans, budgets, risks and governance, and translating scientific objectives into integrated timelines and milestones.
Ipsen London
Leads global operational delivery of early development oncology programs, managing Clinical Project Managers, Monitoring Leads and CTAs. Owns the clinical development plan, CRO and site selection strategy, budgets and timelines, and serves on Asset Teams. Requires deep first-in-human and Phase I oncology trial expertise.
Fortrea Maidenhead
Monitors clinical trials across the UK under a risk-based model, covering oncology and haematology studies plus neuroscience, cell and gene therapies and other therapeutic areas. Requires at least six months of independent monitoring experience and involves 8+ on-site days per month, working with multiple protocols for biotech and biopharma sponsors.
Pfizer New York, United States US$176,600 – US$294,300 pa
Leads global evidence generation strategy for a rare disease therapy, overseeing HEOR studies such as network meta-analyses, economic models, and patient-reported outcomes. Partners with cross-functional teams and country affiliates to support reimbursement and market access, managing vendors and budgets. Requires deep HTA and health economics expertise within a matrix organization.
Pfizer Europe - Any Pfizer Site US$176,600 – US$294,300 pa
Leads global health economics and outcomes research for a rare disease asset, developing evidence generation strategy and HEOR studies such as network meta-analyses, economic models and patient-reported outcomes. Oversees launch deliverables including value dossiers and systematic literature reviews, working with cross-functional and country teams to support reimbursement and patient access.
CSL Maidenhead
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
CSL Opfikon, Switzerland
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
Recursion Remote Opportunity - United Kingdom £136,500 – £167,200 pa
Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead for regulatory interactions and study design from Phase 1-3. Perform and oversee modeling and simulation with tools such as WinNonlin, Monolix, NONMEM and R, and author regulatory sections for IBs, INDs and NDAs. Part of a Pharmacometrics team spanning clinical pharmacology, pharmacometrics and translational modeling, working end-to-end across discovery and development.
